Cargando…

COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System

BACKGROUND: Coronavirus disease 2019 (COVID-19) is an infectious disease caused by SARS-Cov-2, resulting in severe acute respiratory syndrome, with high potential of spreading and infecting humans worldwide. Since December 2019, when the virus was identified in humans, the literature on COVID-19 has...

Descripción completa

Detalles Bibliográficos
Autores principales: Abboud, Hilal, Abboud, Fatima Zahra, Kharbouch, Hanane, Arkha, Yasser, El Abbadi, Najia, El Ouahabi, Abdessamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255736/
https://www.ncbi.nlm.nih.gov/pubmed/32474093
http://dx.doi.org/10.1016/j.wneu.2020.05.193
_version_ 1783539787943116800
author Abboud, Hilal
Abboud, Fatima Zahra
Kharbouch, Hanane
Arkha, Yasser
El Abbadi, Najia
El Ouahabi, Abdessamad
author_facet Abboud, Hilal
Abboud, Fatima Zahra
Kharbouch, Hanane
Arkha, Yasser
El Abbadi, Najia
El Ouahabi, Abdessamad
author_sort Abboud, Hilal
collection PubMed
description BACKGROUND: Coronavirus disease 2019 (COVID-19) is an infectious disease caused by SARS-Cov-2, resulting in severe acute respiratory syndrome, with high potential of spreading and infecting humans worldwide. Since December 2019, when the virus was identified in humans, the literature on COVID-19 has grown exponentially and extrarespiratory symptoms including neurologic symptoms are increasingly highlighted. METHODS: Given the high and increasing number of publications reporting neurologic involvements of SARS-Cov-2, we thought that providing an update for neurologic complications of COVID-19 would be useful for physicians and especially young trainees in neurology and neurosurgery. Indeed, in this review we discuss several neurologic aspects reported in the literature to date including the evidence and pathways of neuroinvasion in COVID-19 and the main neurologic disorders reported in the literature to date, as well as future perspectives and the potential long-term consequence of current neuroinfection in COVID-19 patients. RESULTS: Currently, there is convincing evidence that SARS-CoV-2, the etiologic agent of COVID-19, can affect the nervous system, with damage and neurologic alterations. These neurologic disorders are grouped into several categories, ranging from nonspecific and moderate symptoms such as headache, myalgia, and hyposmia to severe symptoms including cerebrovascular disease and intracranial infections. Severe neurologic symptoms such as acute cerebrovascular disease occur only in a minority of patients with usual risk factors and are associated with poor outcome. However, most COVID-19 patients exhibit only minor or mild neurologic symptoms. CONCLUSIONS: Management of COVID-19 patients should include early clinical, radiologic, and laboratory neurologic assessment, with a close follow-up, especially in severe forms. Future studies should assess late and long-term consequences of current COVID-19 patients with neurologic involvement.
format Online
Article
Text
id pubmed-7255736
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-72557362020-05-29 COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System Abboud, Hilal Abboud, Fatima Zahra Kharbouch, Hanane Arkha, Yasser El Abbadi, Najia El Ouahabi, Abdessamad World Neurosurg Article BACKGROUND: Coronavirus disease 2019 (COVID-19) is an infectious disease caused by SARS-Cov-2, resulting in severe acute respiratory syndrome, with high potential of spreading and infecting humans worldwide. Since December 2019, when the virus was identified in humans, the literature on COVID-19 has grown exponentially and extrarespiratory symptoms including neurologic symptoms are increasingly highlighted. METHODS: Given the high and increasing number of publications reporting neurologic involvements of SARS-Cov-2, we thought that providing an update for neurologic complications of COVID-19 would be useful for physicians and especially young trainees in neurology and neurosurgery. Indeed, in this review we discuss several neurologic aspects reported in the literature to date including the evidence and pathways of neuroinvasion in COVID-19 and the main neurologic disorders reported in the literature to date, as well as future perspectives and the potential long-term consequence of current neuroinfection in COVID-19 patients. RESULTS: Currently, there is convincing evidence that SARS-CoV-2, the etiologic agent of COVID-19, can affect the nervous system, with damage and neurologic alterations. These neurologic disorders are grouped into several categories, ranging from nonspecific and moderate symptoms such as headache, myalgia, and hyposmia to severe symptoms including cerebrovascular disease and intracranial infections. Severe neurologic symptoms such as acute cerebrovascular disease occur only in a minority of patients with usual risk factors and are associated with poor outcome. However, most COVID-19 patients exhibit only minor or mild neurologic symptoms. CONCLUSIONS: Management of COVID-19 patients should include early clinical, radiologic, and laboratory neurologic assessment, with a close follow-up, especially in severe forms. Future studies should assess late and long-term consequences of current COVID-19 patients with neurologic involvement. Elsevier Inc. 2020-08 2020-05-28 /pmc/articles/PMC7255736/ /pubmed/32474093 http://dx.doi.org/10.1016/j.wneu.2020.05.193 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Abboud, Hilal
Abboud, Fatima Zahra
Kharbouch, Hanane
Arkha, Yasser
El Abbadi, Najia
El Ouahabi, Abdessamad
COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System
title COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System
title_full COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System
title_fullStr COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System
title_full_unstemmed COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System
title_short COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System
title_sort covid-19 and sars-cov-2 infection: pathophysiology and clinical effects on the nervous system
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255736/
https://www.ncbi.nlm.nih.gov/pubmed/32474093
http://dx.doi.org/10.1016/j.wneu.2020.05.193
work_keys_str_mv AT abboudhilal covid19andsarscov2infectionpathophysiologyandclinicaleffectsonthenervoussystem
AT abboudfatimazahra covid19andsarscov2infectionpathophysiologyandclinicaleffectsonthenervoussystem
AT kharbouchhanane covid19andsarscov2infectionpathophysiologyandclinicaleffectsonthenervoussystem
AT arkhayasser covid19andsarscov2infectionpathophysiologyandclinicaleffectsonthenervoussystem
AT elabbadinajia covid19andsarscov2infectionpathophysiologyandclinicaleffectsonthenervoussystem
AT elouahabiabdessamad covid19andsarscov2infectionpathophysiologyandclinicaleffectsonthenervoussystem